Jeffrey M. Farma, MD, FACS

Jeffrey Farma, MD, FACS Featured on SurgOnc Today® Podcast

Fox Chase Cancer Center surgical oncologist Jeffrey Farma, MD, FACS, interviews James Jakub, MD, from Mayo Clinic Jacksonville, FL and Luke Rothermel, MD, MPH, from University Hospitals-Cleveland Medical Center Cleveland, OH on the evaluation, workup and treatment of patients with Merkel cell carcinoma.

Listen to Podcast

Jeffrey Farma, MD, FACS, Featured on Narratives of North Broad Podcast

Fox Chase Cancer Center’s Jeffrey Farma, MD, FACS, was guest speaker on the Narratives of North Broad Podcast - hosted by Lewis Katz School of Medicine student Hank Davis and Michael Vitez, Director of Temple's Narrative Medicine program.

Listen to Podcast

Fox Chase’s Jeffrey Farma Admitted to Academy as Master Surgeon Educator

September 2, 2020—Fox Chase Cancer Center’s Jeffrey Farma, MD, FACS, was recently admitted to the prestigious American College of Surgeons Academy of Master Surgeon Educators.

Read Article

Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.

Request an Appointment

Call 888-369-2427

Request Online

Clinical Locations

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
Phone: 888-369-2427

Chair, Department of Surgery

Surgical Director, Melanoma and Skin Cancer Program

Professor, Department of Surgery

NCCN, Non-Melanoma Skin Cancer Panel Member

Specialties

Surgical Oncology

Areas of Expertise

Neuroendocrine Tumors, Stomach (Gastric) Cancer, Melanoma, Skin Cancer, GIST (Gastrointestinal Stromal Tumor), Sarcoma, Colorectal Cancer

Treatment Focus

Colorectal cancer, melanoma, sarcoma, minimally invasive and robotic surgery, isolated limb infusion for in-transit melanoma and extremity sarcomas.

Research Program

Cancer Signaling and Microenvironment

Distinctions

Treatment Philosophy

It is an honor to be part of the staff of the Fox Chase Cancer Center. My initial exposure occurred during a rotation as a Temple University Medical School student at Fox Chase that led me down the path of Surgical Oncology. As a native Philadelphian, I am privileged to work at such an esteemed institution. I was enthralled then by the dedicated care of the staff in dealing with all aspects of treating patients diagnosed with cancer, and I hope to continue this throughout my career at Fox Chase... Expand

I trained in general surgery at Temple University Hospital. During my fellowship at the National Cancer Institute in Bethesda, Maryland, I learned from experts in the field of surgical oncology about clinical trial design, experimental therapeutics and the importance of bench-to-bedside research to progress the fight against cancer. I encountered patients with very complex problems, and the greatest lesson I learned was there are always treatment options, utilizing all different types of techniques including radiation, chemotherapy and surgery.

My clinical surgical oncology fellowship at the Moffitt Cancer Center in Tampa, Florida has provided me with an extensive understanding of the multidisciplinary approach to treating patients with cancer. One of the greatest benefits of a cancer center like Fox Chase is the close knit group of expert physicians from all specialties that are constantly interacting and providing the highest level of care using the most innovative strategies to treat all aspects of cancer. I have developed a particularly strong interest in the surgical and multimodal treatment of patients with Melanoma, Sarcoma and Colorectal cancers, using traditional surgery, regional therapies, and minimally invasive techniques. I have the operative expertise to perform many of these complex procedures using laparoscopic, robotic, and TAMIS (transanal minimally invasive surgery) techniques and have had advanced training in using newest techniques. I am an expert in the treatment of colorectal cancer including; sphincter sparing and nerve sparing resections, and treating patients with hereditary colorectal cancer syndromes.

For melanoma and sarcoma that has regional spread in the extremities I offer a minimally invasive technique call Isolated Limb Infusion, and perform minimally invasive inguinal lymph node dissections.

Most importantly, I hold my patients as my number one priority. I will spend as much time as necessary educating, answering questions and providing guidance for each individual patient to help them throughout each stage of treatment. I believe in candid discussions, where both the patients and families goals and expectations are openly communicated. We will work together as a team to formulate a treatment plan. My personal goal is to treat and care for every patient with the same compassion and honesty as if they were a friend or family member. Collapse

Educational Background

Fellow, Surgical Oncology, Moffitt Cancer Center, Tampa, FL, 2009
Administrative Chief Resident, Department of Surgery, Temple University Hospital, Philadelphia, PA, 2007
Chief Resident, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2006
Fellow, Surgical Oncology, Surgery Branch, National Cancer Institute, NIH, Bethesda, MD, 2005
Resident, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2003
MD, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2000

Memberships

National Comprehensive Cancer Network (NCCN)
- Non-Melanoma Skin Cancer Panel
Academy of Master Surgeon Educators - Associate Member
American College of Surgeons
American College of Surgeons Oncology Group (ACOSOG)
American Radium Society
American Society of Colon and Rectal Surgeons
Association of Academic Surgery - Candidate Member
College of Physicians of Philadelphia
Connective Tissue Oncology Society (CTOS)
Eastern Cooperative Oncology Group
Metropolitan Philadelphia American College of Surgeons
Midwest Melanoma Partnership (MMP)
North American Neuroendocrine Tumor Society
Pennsylvania Medical Society
Philadelphia Academy of Surgery
Society of Laparoendoscopic Surgeons
Society of Surgical Oncology, vice chair of the Complex General Surgical Oncology Program Directors Committee
Society for Surgery of the Alimentary Tract
Society of University Surgeon
Surgical Biology Club III

Honors & Awards

Philadelphia Magazine Top Doctors, 2018-24
2020 AAS/Colombian Surgical Association International Visiting Professorship Award, 2019
Society of Surgical Oncology European Society of Surgical Oncology Observership, 2019
Castle Connelly national list of Top Doctors^®, Regional Top Doctor 2014-17
Humanitarian Award, Melanoma Research Foundation, 2016
2015 American College of Surgeons Traveling Fellowship to Germany, 2014
Alpha Omega Alpha, National Medical Honor Society, Epsilon Chapter- Honorary Member, 2014
H. Lee Moffitt Cancer Center 2008 Fellow’ Education Research Symposium, Best Clinical Poster Presentation, 2008
Temple University Surgery Resident Research Symposium Award, 2007
H. Taylor Caswell Award, Department of Surgery Teaching Award for outstanding Chief Surgical Resident, 2007
ASCO Foundation Merit Award, 2005

Link to /sites/default/files/styles/patient_story/public/images/patient-stories/IMG_1762.JPG?h=89aecc28&itok=f1FQ2ScR

Michelle Palandro

Sarcoma

Michelle Palandro was a healthy and active 27-year-old woman when she was diagnosed with liposarcoma. After first meeting with an oncologist at a large teaching hospital, Michelle was not convinced that this was the best place for her treatment. She sought a second opinion and was pleased with the compassion and thoroughness of the treatment team at Fox Chase. After undergoing surgery, chemotherapy, and radiation therapy, Michelle is happy to report that she has been cancer free since 2012, and that she gave birth to a healthy baby boy in 2015. "At Fox Chase, every single person I met and every single nurse who took care of me was exceptional."

VIEW PATIENT STORY

Brooke Fuller

Colorectal Cancer

Brooke Fuller enjoys working as a floral designer. She and her husband, Scott, are parents to one five-year-old son, Pierce. In January, 2014, at age 30, Brooke was diagnosed with stage 2 colorectal cancer.

VIEW PATIENT STORY

Research Interests

Melanoma: Molecular profiling, outcomes research, clinical trials, immunotherapy
Colorectal: Molecular and imaging profiling for rectal cancer, outcomes research, clinical trials, quality of life
Sarcoma

Selected Publications

Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis. Annals of surgical oncology, 2019. PubMed

Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM. Granular cell tumor experience at a comprehensive cancer center. J Surg Res, 226:1-7, 2018. PubMed

Goel N, Manstein SM, Ward WH, DeMora L, Smaldone MC, Farma JM, Uzzo RG, Esnaola NF. Does the Surgical Apgar Score predict serious complications after elective major cancer surgery? Journal of Surgical Research, 231:242-7, 2018.

Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbrook BJ, Bilimoria KY, Jake Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS. Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial. Journal of the American College of Surgeons. November 2015.

Schatz TP, Nassif MO, Farma JM. Extensive portal venous gas: Unlikely etiology and outcome. Int J Surg Case Rep. December 2014.

Yeo H, Niland J, Milne D, ter Veer A, Bekail-Saab T, Farma JM, Lai L, Skibber JM, Small W Jr, Wilkinson N, Schrag D, Weiser MR, Incidence of minimally invasive colorectal cancer surgery at national comprehensive cancer network centers. Journal of the National Cancer Institute. December 2014.

Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM. Challenges in Treatment of Angiosarcoma: A Single Institution Experience. The American Journal of Surgery. April 2014.

Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM,. Perlis C Turaka A,. Absolute Lymphocyte Count: a Potential Prognostic Factor for Merkel Cell Carcinoma. Journal of the American Academy of Dermatology. March 2014.

Yeo H, Niland J, Milne D, Veer AT, Bekaii-Saab T, Farma JM, Lai L, Skibber J, Small W, Wilkenson N, Schrag D, Weiser M. Incidence of Minimally Invasive Colorectal Cancer Surgery at National Comprehensive Cancer Network Centers. Journal of the National Cancer Institute. Accepted for publication. January 2014.

Keller D, Thomay AA, Gaughan J, Wu H, Farma JM. Outcomes in Patients with Mucosal Melanomas. Journal of Surgical Oncology. October 2013.

Chen KT, Papavasiliou P, Edwards K, Zhu F, Perlis C, Wu H, Turaka A, Berger A, Farma JM. A better prognosis for merkel cell carcinoma of unknown primary origin. American Journal of Surgery. July 2013.

Arrangoiz R, Papavasiliou P, Siripuapu V, Li T, Watson JC, Hoffman JP, Farma JM, Partial stomach-partitioning gastrojejunostomy as an alternative for palliation in patients with malignant gastric or duodenal outlet obstruction. American Journal of Surgery. May 2013.

Nitzkorski, James, Willis, A, Farma JM, Zhu F, Nick D, Sigurdson, E. Association of race and socioeconomic status and outcomes with patients with rectal cancer. Ann Surg Oncol. January 2013.

Chen KT, Olszanski A, Farma JM. Donor transmission of melanoma following renal transplant. Case Reports in Transplantation. November 2012.

Farma JM, Zager JS, Barnica-elvir V, Puleo CA, Marzban SS, Rollison DE, Messina JL, Sondak VK. A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma. Ann Surg Oncol. November 2012.

Additional Publications

Dr. Jeffery Farma on PubMed

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...

Jeffrey Farma, MD, FACS Featured on SurgOnc Today® Podcast

Listen to Podcast

Jeffrey Farma, MD, FACS, Featured on Narratives of North Broad Podcast

Listen to Podcast

Fox Chase’s Jeffrey Farma Admitted to Academy as Master Surgeon Educator

September 2, 2020—Fox Chase Cancer Center’s Jeffrey Farma, MD, FACS, was recently admitted to the prestigious American College of Surgeons Academy of Master Surgeon Educators.

Read Article